Viibryd gets FDA approval

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating major depressive disorder, the agency said Friday.

The FDA announced the approval of Viibryd (vilazodone hydrochloride), made by New Haven, Conn.-based PGxHealth.

“Major depressive disorder is disabling and prevents a person from functioning normally,” FDA Division of Psychiatry Products director Thomas Laughren said. “Medications affect everyone differently, so it’s important to have a variety of treatment options available to patients who suffer from depression.”